Additionally, miR-486 inhibits cell proliferation, invasion, and migration by downregulating TENM1 expression and affecting the ERK and AKT signalling pathways and epithelial-to-mesenchymal transition in papillary thyroid carcinoma [37]. The gene discussed is AKT1; the disease is thyroid gland papillary carcinoma.